United States · Series B startup

Who invested in mPulse

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$11Mraised across 1 round since 2018, from 1 source

Latest round
Series B, $11MMay 2018
Investors
4
See who backed them

The rounds

  1. May 2018
    Series B$11M

    Reported by FinSMEs

Founders and team

From the SEC filings it signed: 2 on the team.

  • Chelsea KrostExecutive Officer, Directori
  • Gregory GoldnerExecutive Officer, Directori

Everyone who backed them

Bonfire VenturesVC firm1round
OCAInvestment firm1round
EchoHealthno record of our own yet1round
SJF Ventures/ HLMno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list mPulse as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Valspring CapitalVC firmPer its own site
Imbolc PartnersInvestment firmPer its own site

Quick answers about mPulse

Who invested in mPulse?

mPulse's investors include Bonfire Ventures, OCA, EchoHealth and SJF Ventures/ HLM.

How much has mPulse raised?

mPulse has raised $11M across 1 round since 2018.

When did mPulse last raise?

mPulse's most recent round was a Series B of $11M in May 2018.

What was mPulse's biggest round?

Its most recent round, $11M in May 2018, is also its largest on record.

Who backed mPulse first?

mPulse's first round on record, in May 2018, was backed by Bonfire Ventures, OCA and EchoHealth and 1 others.

What stage is mPulse at?

mPulse's latest named round is a Series B, in May 2018.

Where is mPulse based?

mPulse is based in the United States.

Companies like mPulse

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.